These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy. Semah F; Gimenez F; Longer E; Laplane D; Thuillier A; Baulac M Ther Drug Monit; 1994 Dec; 16(6):537-40. PubMed ID: 7878690 [TBL] [Abstract][Full Text] [Related]
3. Is brivaracetam-induced elevation of carbamazepine-epoxide levels common and clinically relevant? - A case series. Steinhoff BJ; Bacher M; Blickhan M; Bernedo V; Dietmann D; Intravooth T; Kornmeier R; Kurth C; Mahn P; Schneider M; Stockinger J; Staack AM Epilepsy Res; 2020 Jan; 159():106236. PubMed ID: 31743818 [TBL] [Abstract][Full Text] [Related]
4. Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program. Brodie MJ; Fakhoury T; McDonough B; Colson AO; Stockis A; Elmoufti S; Whitesides J Epilepsy Res; 2018 Sep; 145():55-62. PubMed ID: 29908435 [TBL] [Abstract][Full Text] [Related]
5. Relationship of carbamazepine reduction rate to seizure frequency during inpatient telemetry. Malow BA; Lynch B; Blaxton TA; Mikati MA Epilepsia; 1994; 35(6):1160-4. PubMed ID: 7988505 [TBL] [Abstract][Full Text] [Related]
6. A double-blind comparison of conventional and controlled-release carbamazepine in healthy subjects. Larkin JG; McLellan A; Munday A; Sutherland M; Butler E; Brodie MJ Br J Clin Pharmacol; 1989 Mar; 27(3):313-22. PubMed ID: 2655682 [TBL] [Abstract][Full Text] [Related]
7. Double-blind withdrawal of phenytoin and carbamazepine in patients treated with progabide for partial seizures. Leppik IE; Brundage RC; Krall R; Cloyd JC; Bowman-Cloyd T; Jacobs MP Epilepsia; 1986; 27(5):563-8. PubMed ID: 3093214 [TBL] [Abstract][Full Text] [Related]
8. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite. Wang RB; Liu LT; Yiu CH; Chang TY Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies. Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974 [TBL] [Abstract][Full Text] [Related]
10. Single-drug therapy with carbamazepine in patients with epilepsy: serum levels and clinical effect. Strandjord RE; Johannessen SI Epilepsia; 1980 Dec; 21(6):655-52. PubMed ID: 6777155 [TBL] [Abstract][Full Text] [Related]
11. Lateral gaze nystagmus in carbamazepine-treated epileptic patients: correlation with total and free plasma concentrations of parent drug and its 10,11-epoxide metabolite. Riva R; Contin M; Albani F; Perucca E; Ambrosetto G; Procaccianti G; Santucci M; Baruzzi A Ther Drug Monit; 1985; 7(3):277-82. PubMed ID: 4049464 [TBL] [Abstract][Full Text] [Related]
12. A comparative pharmacokinetic study of conventional and chewable carbamazepine in epileptic patients. Patsalos PN Br J Clin Pharmacol; 1990 May; 29(5):574-7. PubMed ID: 2350535 [TBL] [Abstract][Full Text] [Related]
13. Double dummy comparison between once and twice daily dosing with modified-release carbamazepine in epileptic patients. McKee PJ; Blacklaw J; Carswell A; Gillham RA; Brodie MJ Br J Clin Pharmacol; 1993 Sep; 36(3):257-61. PubMed ID: 9114913 [TBL] [Abstract][Full Text] [Related]
14. Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: A subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures. Abou-Khalil B; Klein P; Shah A; Ryvlin P; Specchio LM; Gama H; Rocha F; Blum D; Grinnell T; Cheng H; Jung J Epilepsy Res; 2018 Nov; 147():80-86. PubMed ID: 30278294 [TBL] [Abstract][Full Text] [Related]
15. Clarithromycin-carbamazepine interaction: a case report. Albani F; Riva R; Baruzzi A Epilepsia; 1993; 34(1):161-2. PubMed ID: 8422851 [TBL] [Abstract][Full Text] [Related]
16. Monotherapy with conventional and controlled-release carbamazepine: a double-blind, double-dummy comparison in epileptic patients. McKee PJ; Blacklaw J; Butler E; Gillham RA; Brodie MJ Br J Clin Pharmacol; 1991 Jul; 32(1):99-104. PubMed ID: 1888646 [TBL] [Abstract][Full Text] [Related]
17. Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants. Brodie MJ; Forrest G; Rapeport WG Br J Clin Pharmacol; 1983 Dec; 16(6):747-9. PubMed ID: 6661364 [TBL] [Abstract][Full Text] [Related]
18. Controlled evaluation of a supplementary dose of carbamazepine on psychomotor function in epileptic patients. Macphee GJ; McPhail EM; Butler E; Brodie MJ Eur J Clin Pharmacol; 1986; 31(2):195-9. PubMed ID: 3803416 [TBL] [Abstract][Full Text] [Related]
19. Fluctuations in salivary carbamazepine and carbamazepine-10,11-epoxide concentrations during the day in epileptic children. Paxton JW; Aman MG; Werry JS Epilepsia; 1983 Dec; 24(6):716-24. PubMed ID: 6641647 [TBL] [Abstract][Full Text] [Related]
20. Differences in side effects between a conventional carbamazepine preparation and a slow-release preparation of carbamazepine. Persson LI; Ben-Menachem E; Bengtsson E; Heinonen E Epilepsy Res; 1990 Jul; 6(2):134-40. PubMed ID: 2201541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]